Carbidopa monohydrate
Carbidopa monohydrate is a selective DOPA decarboxylase inhibitor used in research to block the peripheral conversion of levodopa to dopamine. It is a key tool in neuroscience and pharmacology for modeling Parkinson's disease and studying dopaminergic pathways in both in vitro and in vivo experimental systems.
Product Specifications
CAS Number
38821-49-7
Product Name Alternative
AhR, cancer, Carbidopa, Carbidopa Hydrate, Carbidopa Monohydrate, Carbidopa monohydrate, ArylHydrocarbonReceptor, Aryl Hydrocarbon Receptor, aromatic-L-amino-acid decarboxylase, disease, Inhibitor, Parkinson's, pancreatic, inhibit, peripheral, SCarbidopa, S (-) -Carbidopa
Field of Research
Immunology & Inflammation, Metabolism Research, Pharmacology & Drug Discovery
Purity
98.11% (May vary between batches)
Solubility
DMSO:5.5 mg/mL (22.52 mM)
Smiles
CC (CC1=CC=C (O) C (O) =C1) (NN) C (O) =O
Molecular Formula
C10H16N2O5
Molecular Weight
244.24
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
